Analysts name 3 'must have' ASX shares for buy and hold investors

Here are three ASX shares that could be strong long term buys…

| More on:
a happy investor with a wide smile points to a graph that shows an upward trending share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're a fan of buy and hold investing, then you may want to look at the "champion" ASX shares listed below.

These are three of Bell Potter's favourite picks for long term-focused investors that it believes could drive superior earnings growth and shareholder value over the coming years.

Its analysts believe these champion shares are must haves for ASX portfolios. Here's why:

Amcor CDI (ASX: AMC)

The first champion ASX share is this packaging giant. The broker believes it is well-placed for growth over the long term following its major acquisition of Bemis in 2019.

Bell Potter explained: "After the acquisition of Bemis Company, the combined group is the global leader in consumer packaging with a footprint encompassing North America, Latin America, Asia Pacific, Europe, Middle East, and Africa. The group offers an attractive combination of defensive earnings in the developed countries with faster growth in emerging markets, which accounted for 26% of group sales in fiscal 2021."

CSL Limited (ASX: CSL)

Another champion stock is CSL. Bell Potter is bullish on this biotherapeutics giant's future thanks partly to its world class portfolio of products, the positive outlook for plasma volume growth, and its burgeoning research and development pipeline.

Bell Potter commented: "A leading global company in the development, manufacture, and distribution of plasma therapies as well as non-plasma biotherapeutic products and influenza related products. The global growth in plasma volumes is expected to be around a solid 8% per annum for the foreseeable future and, in addition, the group is planning to launch new products from its very extensive Research and Development portfolio."

It is also worth noting that since the release of this note, the company has acquired Vifor Pharma for $17 billion. This deal both strengthens and complements CSL's existing product portfolio and is expected to be earnings accretive.

Goodman Group (ASX: GMG)

This property giant is another that Bell Potter has among its champions. Its analysts believe Goodman's exposure to industrial and logistics properties will support its growth over the long term.

Its analysts commented: "One of the world's largest integrated industrial property groups with operations centred around development, management and ownership throughout Australia, New Zealand, Asia, Europe, United Kingdom, North America, and Brazil. The long term outlook for industrial and logistics properties is favourable given the continuing growth in ecommerce (or on-line retail sales) and the growing middle class in developing countries."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended CSL Ltd. The Motley Fool Australia owns and has recommended Amcor Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Two smiling work colleagues discuss an investment or business plan at their office.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares.

Read more »

Two brokers analysing stocks.
Broker Notes

Goldman Sachs says this ASX 200 stock is a buy with 25%+ upside

Let's see why the broker is bullish on this name right now.

Read more »

Happy man holding Australian dollar notes, representing dividends.
Broker Notes

Why this cheap ASX All Ords stock could rise 50% and pay an 11% dividend yield

Goldman Sachs thinks that big returns could be coming for buyers of this stock.

Read more »

Woman using a pen on a digital stock market chart in an office.
Broker Notes

CSL stock: Buy, hold, or sell in 2025?

Let's see what analysts are saying about this blue chip giant at the start of the year.

Read more »

a woman holds a facebook like thumbs up sign high above her head. She has a very happy smile on her face.
Broker Notes

Goldman Sachs says this ASX 200 stock is a top buy in January

The broker is forecasting some big returns for investors this year.

Read more »

A man working in the stock exchange.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys right now.

Read more »

A group of businesspeople clapping.
Broker Notes

2 of the best ASX 200 shares to buy in the Asia-Pacific

Goldman Sachs is speaking very highly about these stocks this month.

Read more »

Excited group of friends sitting on sofa watching sports on TV and celebrating.
Broker Notes

4 ASX 200 shares just upgraded for 2025 by top brokers

Leading brokers are forecasting strong performance in 2025 from these four ASX 200 companies.

Read more »